MINNEAPOLIS–(BUSINESS WIRE)–#EPeeps—Imricor Medical Systems, Inc. (ASX:IMR) Imricor, the global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation products, is pleased to announce that it has entered into a Memorandum of Understanding (MOU) with GE HealthCare.
Under the terms of the MOU, GE HealthCare and Imricor intend to collaborate to interface Imricor�s Advantage-MR EP Recorder/Stimulator and Northstar-MR 3D Mapping System with GE HealthCare MRI scanners. A successful collaboration will enable cardiac electrophysiology (EP) ablation procedures guided by real-time MRI, using Imricors catheters and other disposable devices, to be performed on the GE HealthCare MRI platform. The collaboration with GE HealthCare would expand Imricors potential to interface with GE HealthCares new and currently installed MRI scanners.
Imricors short-term goal is to allow sites with GE HealthCare MRI systems to participate in the upcoming Vision-MR Ablation of Atrial FLutter or VISABL-AFL clinical trial in the US and Vision-MR Ablation of Ventricular Tachycardia or VISABL-VT clinical trial in Europe. The Companys overall goal is to broaden in the choices physicians and hospitals have when choosing an MRI platform for their iCMR labs.
Imricors innovative technology has the potential to bring significant benefit to a large number of cardiac arrhythmia patients, said Anja Brau, PhD, General Manager, GE HealthCare MR Clinical Solutions and Research Collaborations. GE HealthCare has a long-standing history of applying MR to therapy guidance and control; we would be pleased to add Imricors capabilities to provide our customers with more options to treat their patients.
We are thrilled at the prospect of expanding the portfolio of MRI scanners that support Advantage-MR and Northstar-MR technology, said Steve Wedan, Imricors CEO and Chair. The addition of GE HealthCare will give physicians and hospitals significantly more flexibility to use the MRI hardware of their choice, when providing real-time iCMR ablations for their patients. We are grateful to our existing customers who have embraced our real-time iCMR ablation technology, and look forward to making the benefits of this technology even more widely available.
About Imricor
Please visit http://imricor.com/investors/about-imricor/ for more information about Imricor, Foreign Ownership Restrictions, and Forward-Looking Statements.
Contacts
Nick Twohy
Vice President of Marketing, Imricor
Email: nick.twohy@imricor.com
Phone: +1 952 818 8407
PHNOM PENH, CAMBODIA - Media OutReach Newswire - 8 November 2024 - Neak Oknha Chen…
SINGAPORE - Media OutReach Newswire - 8 November 2024 – Singapore's beauty enthusiasts have a…
SINGAPORE - Media OutReach Newswire - 8 November 2024 - The Mineral Boutique, a premier…
Unveiling The Future of Communication: People-Centric, and Hyper-personalised SINGAPORE - Media OutReach Newswire - 8…
SINGAPORE - Media OutReach Newswire - 8 November 2024 - The 2024 Singapore FinTech Festival…
Unveiling The Future of Communication: AI-Powered, People-Centric, and Hyper-personalised SINGAPORE - Media OutReach Newswire -…